903557-29-9

Basic information

• Product Name: (S)-5-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE
• Synonyms: (S)-5-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE;(S)-5-BROMO-INDAN-1-YLAMINE;(S)-5-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE-HCL
• CAS NO: 903557-29-9
• Molecular Formula: C9H10BrN
• Molecular Weight: 212.09
• EINECS: 604-604-1
• Mol File: 903557-29-9.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: (S)-5-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-5-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE(903557-29-9)
• EPA Substance Registry System: (S)-5-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE(903557-29-9)

Safety Data

• Hazardous Substances Data: 903557-29-9(Hazardous Substances Data)

Usage

General Description

The chemical (S)-5-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE is a compound with a molecular formula C9H10BrN. It is a brominated amine derivative of indene, a bicyclic aromatic hydrocarbon. This chemical is used in the synthesis of organic compounds and pharmaceuticals. It has the potential to act as a building block for the development of new drugs and materials. The bromine atom in the molecule provides unique reactivity and can be used in various chemical reactions. Overall, (S)-5-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE is a versatile compound with potential applications in the field of organic chemistry and pharmaceutical development.

Upstream product

• 1038919-63-9 (R)-5-bromo-2,3-dihydro-1H-inden-1-ol 
• 34598-49-7 5-Bromo-1-indanone 
• 34598-50-0 5-bromo-1-indanol 
• 1038919-64-0 (S)-1-azido-5-bromo-2,3-dihydro-1H-indene 
• 185122-74-1 5-bromo-2,3-dihydro-1H-inden-1-one oxime 

Downstream Products

• 903557-31-3 tert-butyl N-[(S)-5-bromo-2,3-dihydroinden-1-yl]carbamate 

Relevant articles and documents

NEW ARYL-BENZOCYCLOALKYL AMIDE DERIVATIVES

The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, A1, A2 and n are as described herein, compositions including the compounds and methods of using the compounds.

COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARY ACTIVATING ACTIVITIES

Compounds of following formula (I) are provided that have both angiontensin Il receptor antagonist activity and PPARy agonist activity. Also provided are pharmaceutical compositions comprising the compounds and methods of treatment of diseases with the co

HETEROBICYCLIC METALLOPROTEASE INHIBITORS

The present invention relates generally to heterobicyclic containing pharmaceutical agents, and in particular, to heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic metalloprotease inhibiting compounds that exhibit an increased potency in relation to currently known metalloprotease inhibitors.